April 28 (SeeNews) - Bulgarian pharmaceuticals manufacturer Sopharma [BUL:SFA] said that its standalone net profit more than doubled to 16.4 million levs ($9.2 million/8.4 million euro) in the first three months of 2023 from 7.1 million levs in the same period of last year, as revenue increased significantly.